Aldeyra Therapeutics, Inc. (13)

Browse by Contract Category

Contracts

Third Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of August 12, 2021 (Filed With SEC on October 28, 2021)
Aldeyra Therapeutics, Inc. Amended and Restated Change in Control Plan (Filed With SEC on August 5, 2021)
Underwriting Agreement among Aldeyra Therapeutics, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters, dated April 28, 2021 (Filed With SEC on April 29, 2021)
Description of Securities (Filed With SEC on March 12, 2020)
Exclusive License Agreement, effective as of July 7, 2016, between the Massachusetts Eye and Ear Infirmary and Helio Vision, Inc (Filed With SEC on March 12, 2020)
Agreement and Plan of Merger, dated as of January 24, 2019, by and among Aldeyra Therapeutics, Inc., Helio Vision, Inc., Halo Merger Sub, Inc., Halo Merger Sub, LLC and Josef von... (Filed With SEC on January 29, 2019)
First Amendment to Loan and Security Agreement, dated April 20, 2021, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the several banks and other financial... (Filed With SEC on April 21, 2021)
Underwriting Agreement among Aldeyra Therapeutics, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters, dated January 13, 2021 (Filed With SEC on January 14, 2021)
Second Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of October 7, 2020 (Filed With SEC on November 5, 2020)
Separation and Consulting Letter Agreement, effective as of March 9, 2020, between the Registrant and David Clark (Filed With SEC on May 7, 2020)
Amendment Number 1 and Waiver Agreement dated December 20, 2018 by and between Helio Vision, Inc. and the Massachusetts Eye and Ear Infirmary (Filed With SEC on March 12, 2020)
Loan and Security Agreement, dated as of March 25, 2019, by and among the Registrant, certain subsidiaries of the Registrant from time to time party thereto, the several banks and... (Filed With SEC on March 26, 2019)
Offer Letter, effective as of April 19, 2018, between the Registrant and David McMullin (Filed With SEC on March 8, 2019)